Clinical trials: Epicardial Fat
Coronary Atherosclerosis
Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT)
The purpose of this study is to determine whether olmesartan medoxomil is effective in the treatment of coronary atherosclerosis progression and epicardial adipose tissue(EAT) volume reduction in patients with coronary…
- Trial name
- NCT02360956
- Testing
- Olmesartan medoxomil tablets, Antihypertensive medication (per doctor suggestion)
- Where
- China
- Volunteers
- 100 people
- Sponsor
- Chinese PLA General Hospital
Heart Failure With Preserved Ejection Fraction
The Relationship Between Pericardial Fat Thickness and Arterial Stiffness in HFpEF Patients
Heart failure with preserved ejection fraction (HFpEF) was considered as a heterogeneous disease with multi-organ and multi-system design, which is related to various complications, such as hypertension, obesity and…
- Trial name
- NCT04594499
- Where
- China
- Volunteers
- 200 people
- Sponsor
- Chongqing Medical University
Chronic Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF)
Precision Subtyping and Prognostic Study of Heart Failure Based on Multi-Omics Integration and Clinical Indicators: A Prospective Single-Center Cohort Study
This is a prospective single-center cohort study conducted at The First Affiliated Hospital of Xinjiang Medical University, aiming to enroll 400 patients with chronic heart failure (including HFrEF, HFmrEF, HFpEF) and 200 healthy…
- Conditions
- Chronic Heart Failure, Heart Failure With Reduced Ejection Fraction (HFrEF), Heart Failure With Preserved Ejection Fraction (HFPEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF)
- Trial name
- HF-MultiOmics (NCT07355088)
- Where
- China
- Volunteers
- 600 people, healthy volunteers welcome
- Sponsor
- Xinjiang Medical University
Cardiovascular Diseases, Atherosclerosis
Ertugliflozin: Cardioprotective Effects on Epicardial Fat
The purpose of this study is to learn if Sodium-Glucose Cotransporter 2 inhibitor (SGLT2i) medications enhance beneficial properties of epicardial adipose tissue including metabolic flexibility, insulin sensitivity, decreased…
- Conditions
- Cardiovascular Diseases, Atherosclerosis, Type 2 Diabetes, Insulin Resistance
- Trial name
- NCT04167761
- Testing
- Ertugliflozin
- Where
- United States
- Volunteers
- 61 people
- Sponsor
- Stanford University
Coronary Artery Disease
Epicardial Fat in Coronary Artery Disease
We hypothesize that human epicardial fat plays a thermogenic role to the myocardium. We hypothesize that epicardial fat may express genes of brown fat and thyroid function that are down-regulated by the presence of coronary…
- Trial name
- NCT03693261
- Testing
- Coronary artery bypass grafting (CABG), Valve replacement
- Where
- United States
- Volunteers
- 43 people
- Sponsor
- University of Miami
Epicardial Fat Tissue (EFT), Chronic Non-Communicable Diseases (NCDs)
Epicardial Fat Tissue and Cardiometabolic Risk in Russian and Asian Populations
Visceral obesity is a well-established risk factor for the development of chronic non-communicable diseases (NCDs). Epicardial fat tissue (EFT) is located on the surface of the myocardium and may directly affect cardiac function…
- Conditions
- Epicardial Fat Tissue (EFT), Chronic Non-Communicable Diseases (NCDs), Visceral Obesity
- Trial name
- EPIGRAPH (NCT07604610)
- Where
- Russia
- Volunteers
- 500 people
- Sponsor
- National Medical Research Center for Therapy and Preventive Medicine
Atrial Fibrillation (AF)
Finerenone After Catheter Ablation to Reduce Atrial Fibrillation Recurrence
Atrial fibrillation (AF) is a common heart rhythm disorder associated with stroke, heart failure, and increased mortality. Catheter ablation with pulmonary vein isolation (PVI) is an effective rhythm-control strategy, but 20-30%…
- Trial name
- FINE-CA (NCT07799519)
- Testing
- Finerenone
- Where
- Taiwan
- Volunteers
- 40 people
- Sponsor
- National Cheng-Kung University Hospital
Epicardial Fat, Obesity
CT Evaluation of Cardiovascular Risk Markers in Obese Patients
Obesity is a chronic metabolic disorder : it leads to coronary heart disease and early atherosclerosis. Coronary artery calcium measured by CT is known as a robust predictor to predict risk for cardiac events in symptomatic and…
- Conditions
- Epicardial Fat, Obesity, Cardiovascular Risks Markers, Metabolic Syndrome
- Trial name
- RisqOScan (NCT03111693)
- Testing
- Unenhanced Coro-CT
- Where
- France
- Volunteers
- 123 people
- Sponsor
- University Hospital, Clermont-Ferrand
Hiv Infection
Epicardial Adipose Tissue And Coronary Risk In HIV-Infected Patients
Protocol date and version RCB Id : 2013-A00547-38 Etude ANRS EP 52 PIECVIH Title of Study: EPICARDIAL ADIPOSE TISSUE AND CORONARY RISK IN HIV-INFECTED PATIENTS Short title - PIECVIH study Sponsor French National Institute for…
- Trial name
- ANRS EP 52 (NCT01899196)
- Testing
- blood sampling,
- Where
- France
- Volunteers
- 24 people, healthy volunteers welcome
- Sponsor
- ANRS, Emerging Infectious Diseases
Atrial Fibrillation
Contribution of Computed Tomography and Cardiac-MRI in Atrial Fibrillation Ablation
Atrial fibrillation ablation (AF) is a standard interventional treatment for patients with symptomatic AF refractory to medical treatment.
- Trial name
- CTStrain-AF (NCT04281329)
- Testing
- Magnetic resonance imaging
- Where
- France
- Volunteers
- 130 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
CABG-patients, Heart Failure
Safety and Efficacy of Epicardial Implantation of Collagen Membranes With Allogeneic Adipose Derived Stem Cells
The Cardiomesh II clinical trial is a phase I open label study intended to enrol 10 patients to evaluate the safety and efficacy of surgical epicardial implantation of a membrane seeded with allogeneic adipose tissue derived stem…
- Conditions
- CABG-patients, Heart Failure, Myocardial Infarction (MI)
- Trial name
- CARDIOMESH II (NCT06956807)
- Testing
- VB-C01 cellularised patch
- Where
- Poland
- Volunteers
- 10 people
- Sponsor
- Viscofan
Type 2 Diabetes, Overweight
Effect of Liraglutide on Epicardial Fat in Subjects With Type 2 Diabetes
The purpose of this research study is to learn about the effect of Liraglutide, (Victoza®), on the fat surrounding the heart.Excessive amount of the fat around the heart is common in people with type 2 diabetes and can be…
- Conditions
- Type 2 Diabetes, Overweight, Obesity
- Trial name
- NCT02014740
- Testing
- Liraglutide, Metformin
- Where
- United States
- Volunteers
- 100 people
- Sponsor
- University of Miami
Epicardial Fat, Visceral Fat
Epicardial Fat, Visceral Fat and Coronary Atherosclerosis
Background: Visceral fat is increasingly associated with metabolic syndrome and with fatty liver, a condition carrying a high risk of cardiovascular disease.
- Conditions
- Epicardial Fat, Visceral Fat, Atherosclerosis
- Trial name
- NCT01344694
- Testing
- patient with liver fat, pts. with excess of visceral fat, control
- Where
- Israel
- Volunteers
- 110 people, healthy volunteers welcome
- Sponsor
- Ziv Hospital
Heart Failure With Preserved Ejection Fraction (HFPEF)
The Role of Epicardial Adiposity in Heart Failure With Preserved Ejection Fraction
In this study the investigators are aiming to recruit 130 patients with heart failure with preserved ejection fraction who are obese and non-obese to undergo CT and MRI scans, as well as some other investigations including blood…
- Trial name
- EAT HFpEF (NCT06768437)
- Where
- United Kingdom
- Volunteers
- 130 people
- Sponsor
- University of Leicester
Dyslipidemia
Assessment of Epicardial Fat Thickness in Children With Familial Dyslipidemia
Aim of the study: 1- Detect common types of familial dyslipidemia. 2- Significance and relationship between Epicardial fat thickness and familial dyslipidemia.
- Trial name
- NCT06101771
- Testing
- echoCARDIOGRAPHY
- Volunteers
- 42 people, healthy volunteers welcome
- Sponsor
- Assiut University
Essential Hypertension, Diabetes Mellitus
Effects Of Losartan On Myocardial Structure In Diabetic Hypertensive Patients With Left Ventricular
The anthypertensive treatment with Losartan may have benefits beyond blood pressure reduction on myocardial structure and function in hypertensive diabetic patients.
- Trial name
- NCT00659451
- Testing
- Losartan, Amlodipine
- Where
- Italy
- Volunteers
- 100 people
- Sponsor
- University of Pavia
Ankylosing Spondylitis
Epicardial Adipose Tissue Thickness and the Related Factors in Patients With Ankylosing Spondylitis
The aim of this study was to assess the EATT and the related factors in patients with AS and to compare the results with that of the healthy controls'
- Trial name
- NCT06094686
- Testing
- epicardial adipose tissue thickness
- Where
- Turkey (Türkiye)
- Volunteers
- 61 people, healthy volunteers welcome
- Sponsor
- Istanbul Physical Medicine Rehabilitation Training and Research Hospital
Lupus
Cardiac Imaging in Systemic Disorders: the ORACLES Registry
Autoimmune diseases affect a total of 5 to 10% of the population. These diseases are associated with an increased risk of developing cardiovascular pathologies.
- Trial name
- ORACLES (NCT07134166)
- Testing
- data collection
- Volunteers
- 1,500 people
- Sponsor
- Assistance Publique - Hôpitaux de Paris
Atrial Fibrillation, Ischemic Heart Disease
The New Pharmaceutical Composition Containing Botulinum Toxin to Treat Atrial Fibrillation
The aim of this prospective randomized double-blind study was to compare the efficacy of new pharmaceutical composition containing botulinum toxin injection in epicardial fat pads for preventing recurrences of atrial…
- Trial name
- NCT02982434
- Testing
- Pharmaceutical composition containing botulinum toxin, 0.9% normal saline, Coronary artery bypass grafting
- Where
- 2 sites in Russia
- Volunteers
- 180 people
- Sponsor
- Meshalkin Research Institute of Pathology of Circulation
Type 2 Diabetes
Dapagliflozin Effects on Epicardial Fat
The purpose of this research study is to learn about the effect of Dapagliflozin (Farxiga) on the fat of the heart.
- Trial name
- NCT02235298
- Testing
- Dapagliflozin, Metformin
- Where
- United States
- Volunteers
- 100 people
- Sponsor
- University of Miami